Last quarter (Q ), CytRx's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, CytRx's net income was $-996.34K. See CytRx’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 250.00K	$ 100.00K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 5.96M	$ 5.98M	$ 6.83M	$ 7.86M	$ 8.50M	$ 28.46M
Operating Income	$ -5.96M	$ -5.98M	$ -6.83M	$ -7.86M	$ -8.25M	$ -28.36M
Net Non Operating Interest Income Expense	$ 9.69K	$ 16.82K	$ 119.27K	$ 351.97K	$ -1.36M	$ -3.47M
Other Income Expense	$ -6.86M	$ -7.21M	$ 10.07K	$ -12.52K	$ 529.70K	$ 1.37M
Pretax Income	$ -12.81M	$ -13.18M	$ -6.70M	$ -7.52M	$ -9.08M	$ -30.45M
Tax Provision	-	$ 0.00	$ 800.00	$ 800.00	$ 800.00	$ 800.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -13.39M	$ -13.35M	$ -6.70M	$ -7.16M	$ -12.71M	$ -34.99M
Basic EPS	$ -0.34	$ -0.35	$ -0.19	$ -0.22	$ -0.41	$ -1.46
Diluted EPS	$ -0.34	$ -0.35	$ -0.19	$ -0.22	$ -0.41	$ -1.46
Basic Average Shares	$ 160.93M	$ 37.58M	$ 34.65M	$ 33.26M	$ 30.95M	$ 24.04M
Diluted Average Shares	$ 160.93M	$ 37.58M	$ 34.65M	$ 33.26M	$ 30.95M	$ 24.04M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 5.96M	$ 5.98M	$ 6.83M	$ 7.86M	$ 8.50M	$ 28.46M
Net Income From Continuing And Discontinued Operation	$ -12.81M	$ -13.18M	$ -6.70M	$ -7.16M	$ -12.71M	$ -34.99M
Normalized Income	$ -12.81M	$ -13.18M	$ -6.70M	$ -7.52M	$ -9.46M	$ -31.27M
Interest Expense	-	-	-	$ 0.00	$ 1.72M	$ 3.83M
EBIT	$ -5.96M	$ -5.98M	$ -6.83M	$ -7.86M	$ -7.36M	$ -26.62M
EBITDA	$ -5.81M	$ -5.97M	$ -6.80M	$ -7.84M	$ -7.33M	$ -26.51M

Currency in USD

CytRx Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing